Abstract:Objective MiRNAs microarray was employed to determine the differential time-specific expression of miRNAs in ventricular myocardium of fetus with ventricular septal defect(VSD) in the different gestational ages(the first trimester and the second trimester).Methods The VSD group was recruited from the fetuses with VSD aborted for pathological factors,and was divided into VSD subgroups:subgroup 1 for the first trimester and subgroup 2 for the second trimester according to the gestational ages.The control group was chosen from the fetuses of inevitable abortion without cardiac malformations,and was divided into the control subgroups in the same way.The fetal ventricular myocardiums were acquired and RNAs were extracted and processed.The Agilent Human 2.0 microarrays containing 723 known miRNAs were applied to get the data about miRNAs expression changes,the data were analyzed by bioinformatics methods:differential miRNAs expression analysis,target gene ontology analysis and pathway-express analysis.Differential expressions of miRNAs microarray were certificated by real-time PCR.Results VSD group and control group had 6 fetuses,respectively,with 3 fetuses in the first trimester and 3 in the second trimester,respectively.①There were 33 differential time-specific expression of miRNAs in the 2 VSD subgroups.Expressions of 19 miRNAs were up-regulated in subgroup 1 and down-regulated in subgroup 2.Expressions of 14 miRNAs were up-regulated in subgroup 1 and down-regulated in subgroup 2.②A total of 2 761 target genes were predicted by bioinformatic methods.The most of target genes were directly associated with the key genes of heart development(such as TBX5,GATA4,TBX1,NKX2-5,etc.).③The gene ontology analysis indicated that target genes were mainly related to the cellular process,metabolic process and biological regulation,and accounted for 23.5 %,18.3%,17.7% of the total number of target genes,respectively.④The pathway-express analysis indicated that the WNT signaling pathway played an important role in both VSD subgroups.⑤Four miRNAs(hsa-miR-19a,hsa-let-7e,hsa-miR-134 and hsa-miR-206) were randomly selected and verified by real-time PCR,the results of quantitative PCR were basically consistent with the microarray results.Conclusions The differential time-specific expression of miRNAs may play an important role in the occurrence and development of fetal VSD malformations,but it needs confirmation by study with larger sample size.These predicted target genes were mainly related to cell growth,differentiation and metabolism;partially were directly associated with the key genes of heart development;partially were key factors of the WNT signaling pathway.The occurrence and development of fetal VSD malformations were the joint results of imbalance gene expression which functioned at different levels under the participation of miRNAs.

Roles of Mir-1-1 and Mir-181c in Ventricular Septal Defects

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

Characterization of Circulating MicroRNA Expression in Patients with a Ventricular Septal Defect

Expression of Mir-126 and Mir-508-5p in Endothelial Progenitor Cells is Associated with the Prognosis of Chronic Heart Failure Patients

Mirna-940 Reduction Contributes to Human Tetralogy of Fallot Development.

The Role of Microrna -155,Microrna -222 and Mitogen -Activated Protein Kinase Signaling Pathway in Ven-Tricular Septal Defect

Differential Time-Specific Expression of Mirnas in Ventricular Myocardium of Fetus with Ventricular Septal Defect

Microrna Expression Profiling in Fetal Single Ventricle Malformation Identified by Deep Sequencing.

Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects

Identification Of Novel Single-Nucleotide Variants With Potential Of Mediating Malfunction Of Microrna In Congenital Heart Disease

MicroRNA-34a Modulates the Notch Signaling Pathway in Mice with Congenital Heart Disease and Its Role in Heart Development.

NOTCH1 Gene MicroRNA Target Variation and Ventricular Septal Defect Risk.

Micrornas in Cardiovascular Development

Mirnas In Cardiac Development

MicroRNAs: Novel Regulators of the Heart.

<i>NOTCH1</i> Gene MicroRNA Target Variation and Ventricular Septal Defect Risk

Expression And Function Of Mir-92a In Ventricular Remodeling After Pci Treatment Of Acute Myocardial Infarction

Elevated Microrna-187 Causes Cardiac Endothelial Dysplasia to Promote Congenital Heart Disease Through Inhibition of NIPBL

MicroRNAs in cardiac development and diseases

Abnormal Expression of Mir-331 Leads to Impaired Heart Function

E0164 Dysregulation of Mir-1 after Left Ventricular Hypertrophy Reveals a Role of Mir-1 in Ventricular Arrhythmia Occurred in the Hypertensive Heart